AR SB394

Expands the definition of who may receive an epinephrine certificate to include "authorized entities" (restaurants, amusement parks, sports arenas) where allergens may be present, in addition to individuals like parents, teachers, and camp counselors.

Allows authorized entities and their employees to obtain prescriptions for epinephrine auto-injectors in the entity's name and provide or administer them to individuals experiencing anaphylaxis, regardless of prior allergy diagnosis or prescription.

Extends legal immunity from civil liability to authorized entities, their employees, physicians, medical facilities, and training providers who act in good faith in providing emergency care with auto-injectable epinephrine, except in cases of gross negligence or willful misconduct.

Requires authorized entities to ensure expected users complete anaphylaxis training every two years, maintain epinephrine in secure locations per manufacturer guidelines, activate emergency services immediately upon use, and notify 911 dispatch of the existence and location of epinephrine supplies.

Mandates authorized entities submit incident reports to the Department of Health when epinephrine is provided or administered, with the department publishing annual summaries of these reports.